BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol 2012; 4(4): 68-70 [PMID: 22532878 DOI: 10.4251/wjgo.v4.i4.68] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 69] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Anwar A, Uddin N, Siddiqui BS, Siddiqui RA, Begum S, Choudhary MI. A natural flavonoid lawsonaringenin induces cell cycle arrest and apoptosis in HT-29 colorectal cancer cells by targeting multiple signalling pathways. Mol Biol Rep 2018;45:1339-48. [DOI: 10.1007/s11033-018-4294-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Chen Q, Meng F, Wang L, Mao Y, Zhou H, Hua D, Zhang H, Wang W. A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients. Sci Rep 2017;7:7059. [PMID: 28765596 DOI: 10.1038/s41598-017-07491-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
3 Chen H, Xiao Q, Hu Y, Chen L, Jiang K, Tang Y, Tan Y, Hu W, Wang Z, He J, Liu Y, Cai Y, Yang Q, Ding K. ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138. J Exp Clin Cancer Res 2017;36:78. [PMID: 28606130 DOI: 10.1186/s13046-017-0548-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
4 Farhood B, Raei B, Malekzadeh R, Shirvani M, Najafi M, Mortezazadeh T. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. Contemp Oncol (Pozn) 2019;23:7-15. [PMID: 31061631 DOI: 10.5114/wo.2019.84112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chen CC, Sureshbabul M, Chen HW, Lin YS, Lee JY, Hong QS, Yang YC, Yu SL. Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer. Evid Based Complement Alternat Med 2013;2013:541695. [PMID: 23970932 DOI: 10.1155/2013/541695] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
6 Roy N, Nazeem PA, Babu TD, Abida PS, Narayanankutty A, Valsalan R, Valsala PA, Raghavamenon AC. EGFR gene regulation in colorectal cancer cells by garlic phytocompounds with special emphasis on S-Allyl-L-Cysteine Sulfoxide. Interdiscip Sci 2018;10:686-93. [PMID: 28349439 DOI: 10.1007/s12539-017-0227-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
7 Guo J, Wang B, Hou W, Ma K. Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus. Open Life Sci 2020;15:267-73. [PMID: 33817215 DOI: 10.1515/biol-2020-0030] [Reference Citation Analysis]
8 Seo YS, Kim MS, Yoo HJ, Jang WI. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer. World J Gastroenterol 2014; 20(8): 2005-2013 [PMID: 24587675 DOI: 10.3748/wjg.v20.i8.2005] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
9 Wang G, Shen W, Liu C, Liu Y, Wu T, Cui X, Yu T, Zhu Y, Song J, Du P, Cui L. Phosphorylase kinase β affects colorectal cancer cell growth and represents a novel prognostic biomarker. J Cancer Res Clin Oncol 2017;143:971-80. [DOI: 10.1007/s00432-017-2362-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Shim HJ, Lee R, Shin MH, Kim HN, Kweon SS. Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses. Cancer Epidemiol 2016;45:108-11. [PMID: 27792933 DOI: 10.1016/j.canep.2016.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Roukeyan•Kudalaiti, Yue N, Liang LP, Zhao F. Clinicopathological features and expression of hMLH1 and hMSH2 in Uygur and Han patients with colorectal carcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(15): 2382-2388 [DOI: 10.11569/wcjd.v23.i15.2382] [Reference Citation Analysis]
12 Babu B, Palanisamy S, Vinosha M, Anjali R, Kumar P, Pandi B, Tabarsa M, You S, Prabhu NM. Bioengineered gold nanoparticles from marine seaweed Acanthophora spicifera for pharmaceutical uses: antioxidant, antibacterial, and anticancer activities. Bioprocess Biosyst Eng 2020;43:2231-42. [PMID: 32683506 DOI: 10.1007/s00449-020-02408-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Huang B, Liu X, Sun C, Wang L, Yang L. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study. Cancer Biomark 2017;18:433-9. [PMID: 28106544 DOI: 10.3233/CBM-160378] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Sun K, Gong A, Liang P. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients. Tumour Biol. 2015;36:1549-1559. [PMID: 25355595 DOI: 10.1007/s13277-014-2721-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
15 Cai Z, Han S, Li Z, He L, Zhou J, Huang W, Xu Y. A genome-wide assessment of variations of primary colorectal cancer maintained in metastases. Gene 2016;595:18-24. [DOI: 10.1016/j.gene.2016.09.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Asadzadeh Aghdaei H, Nazemalhosseini Mojarad E, Ashtari S, Pourhoseingholi MA, Chaleshi V, Anaraki F, Haghazali M, Zali MR. Polyp detection rate and pathological features in patients undergoing a comprehensive colonoscopy screening. World J Gastrointest Pathophysiol 2017; 8(1): 3-10 [PMID: 28251034 DOI: 10.4291/wjgp.v8.i1.3] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
17 Mohd Yunos RI, Ab Mutalib NS, Tieng FYF, Abu N, Jamal R. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine. Biomolecules 2020;10:E476. [PMID: 32245111 DOI: 10.3390/biom10030476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ku S, Park MS, Ji GE, You HJ. Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism. Int J Mol Sci 2016;17:E1544. [PMID: 27649150 DOI: 10.3390/ijms17091544] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
19 Zhao L, Bao F, Yan J, Liu H, Li T, Chen H, Li G. Poor prognosis of young patients with colorectal cancer: a retrospective study. Int J Colorectal Dis 2017;32:1147-56. [DOI: 10.1007/s00384-017-2809-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
20 Wang HM, Zhou S, Wang W. Trends of incidence and characteristics of colorectal cancer in the population in Inner Mongolia. Shijie Huaren Xiaohua Zazhi 2014; 22(30): 4705-4708 [DOI: 10.11569/wcjd.v22.i30.4705] [Reference Citation Analysis]
21 Karbasi A, Borhani N, Daliri K, Kazemi B, Manoochehri M. Downregulation of external death receptor genes FAS and DR5 in colorectal cancer samples positive for human papillomavirus infection. Pathology - Research and Practice 2015;211:444-8. [DOI: 10.1016/j.prp.2015.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
22 Kim HK, Lwin MO. Cultural Effects on Cancer Prevention Behaviors: Fatalistic Cancer Beliefs and Risk Optimism Among Asians in Singapore. Health Communication 2016;32:1201-9. [DOI: 10.1080/10410236.2016.1214224] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
23 Nawi AM, Chin SF, Mazlan L, Jamal R. Delineating colorectal cancer distribution, interaction, and risk prediction by environmental risk factors and serum trace elements. Sci Rep 2020;10:18670. [PMID: 33122698 DOI: 10.1038/s41598-020-75760-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kimura Y, Morohashi S, Yoshizawa T, Suzuki T, Morohashi H, Sakamoto Y, Koyama M, Murata A, Kijima H, Hakamada K. Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer. Mol Med Rep 2016;13:1551-7. [PMID: 26676225 DOI: 10.3892/mmr.2015.4687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang Y, Fu J, Zhang Z, Qin H. miR-486-5p regulates the migration and invasion of colorectal cancer cells through targeting PIK3R1. Oncol Lett 2018;15:7243-8. [PMID: 29725442 DOI: 10.3892/ol.2018.8233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
26 Song WY, Zhang X, Zhang Q, Zhang PJ, Zhang R. Clinical value evaluation of serum markers for early diagnosis of colorectal cancer. World J Gastrointest Oncol 2020; 12(2): 219-227 [PMID: 32104552 DOI: 10.4251/wjgo.v12.i2.219] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Bae N, Park S, Lim S. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea. Eur J Oncol Nurs 2014;18:72-7. [PMID: 24183583 DOI: 10.1016/j.ejon.2013.09.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
28 Qin S, Xu RH, Shen L, Xu J, Bai Y, Yang L, Deng Y, Chen ZD, Zhong H, Pan H, Guo W, Shu Y, Yuan Y, Zhou J, Xu N, Liu T, Ma D, Wu C, Cheng Y, Chen D, Li W, Sun S, Yu Z, Cao P, Chen H, Wang J, Wang S, Wang H, Wang N, Zhang B, Zhang Q, Su W, Guo X, Li J. Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer. Onco Targets Ther 2021;14:4439-50. [PMID: 34408440 DOI: 10.2147/OTT.S307273] [Reference Citation Analysis]
29 Yusuf I, Pardamean B, Baurley JW, Budiarto A, Miskad UA, Lusikooy RE, Arsyad A, Irwan A, Mathew G, Suriapranata I, Kusuma R, Kacamarga MF, Cenggoro TW, McMahan C, Joyner C, Pardamean CI. Genetic risk factors for colorectal cancer in multiethnic Indonesians. Sci Rep 2021;11:9988. [PMID: 33976257 DOI: 10.1038/s41598-021-88805-4] [Reference Citation Analysis]
30 Weng W, Liu N, Toiyama Y, Kusunoki M, Nagasaka T, Fujiwara T, Wei Q, Qin H, Lin H, Ma Y, Goel A. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer. Mol Cancer. 2018;17:16. [PMID: 29382334 DOI: 10.1186/s12943-018-0767-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 15.0] [Reference Citation Analysis]
31 Chandrasinghe PC, Ediriweera DS, Hewavisenthi J, Kumarage SK, Fernando FR, Deen KI. Colorectal cancer burden and trends in a South Asian cohort: experience from a regional tertiary care center in Sri Lanka. BMC Res Notes 2017;10:535. [PMID: 29084610 DOI: 10.1186/s13104-017-2869-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
32 Khoshdel AR, Alimohamadi Y, Ziaei M, Ghaffari HR, Azadi S, Sepandi M. The prediction incidence of the three most common cancers among Iranian military community during 2007-2019: a time series analysis. J Prev Med Hyg 2019;60:E256-61. [PMID: 31650063 DOI: 10.15167/2421-4248/jpmh2019.60.3.1058] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Wu H, Kang H, Liu Y, Xiao Q, Zhang Y, Sun M, Liu D, Wang Z, Zhao H, Yao W. Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis. Pharmacogenomics. 2013;14:897-911. [PMID: 23746184 DOI: 10.2217/pgs.13.78] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
34 Azzani M, Yahya A, Roslani AC, Su TT. Catastrophic Health Expenditure Among Colorectal Cancer Patients and Families: A Case of Malaysia. Asia Pac J Public Health 2017;29:485-94. [DOI: 10.1177/1010539517732224] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
35 Li Z, Yu D, Gan M, Shan Q, Yin X, Tang S, Zhang S, Shi Y, Zhu Y, Lai M, Zhang D. A genome-wide assessment of rare copy number variants in colorectal cancer. Oncotarget 2015;6:26411-23. [PMID: 26315111 DOI: 10.18632/oncotarget.4621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
36 Abdullah M, Syam AF, Meilany S, Laksono B, Prabu OG, Bekti HS, Indrawati L, Makmun D. The Value of Caspase-3 after the Application of Annona muricata Leaf Extract in COLO-205 Colorectal Cancer Cell Line. Gastroenterol Res Pract 2017;2017:4357165. [PMID: 28487731 DOI: 10.1155/2017/4357165] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
37 Ghodsi M, Jafarian AH, Montazer M, Sadeghian MH, Forghanifard MM. Diagnostic clinical relevance of developmental pluripotency-associated 2 (DPPA2) in colorectal cancer. International Journal of Surgery 2015;13:193-7. [DOI: 10.1016/j.ijsu.2014.11.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Kashani N, Bezmin Abadi AT, Rahimi F, Forootan M. FadA-positive Fusobacterium nucleatum is prevalent in biopsy specimens of Iranian patients with colorectal cancer. New Microbes New Infect 2020;34:100651. [PMID: 32025313 DOI: 10.1016/j.nmni.2020.100651] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
39 Brooks AW, Priya S, Blekhman R, Bordenstein SR. Gut microbiota diversity across ethnicities in the United States. PLoS Biol 2018;16:e2006842. [PMID: 30513082 DOI: 10.1371/journal.pbio.2006842] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 25.8] [Reference Citation Analysis]
40 Kuo LJ, Ngu JC, Huang YJ, Lin YK, Chen CC, Tong YS, Huang SC, Hu CC, Tan SH. Anorectal complications after robotic intersphincteric resection for low rectal cancer. Surg Endosc 2017;31:4466-71. [PMID: 28374259 DOI: 10.1007/s00464-017-5499-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
41 Soffer S, Klang E, Tau N, Zemet R, Ben-Horin S, Barash Y, Kopylov U. Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics. Therap Adv Gastroenterol 2020;13:1756284820941153. [PMID: 32733602 DOI: 10.1177/1756284820941153] [Reference Citation Analysis]
42 Nazemalhosseini-Mojarad E, Kishani Farahani R, Mehrizi M, Baghaei K, Yaghoob Taleghani M, Golmohammadi M, Peyravian N, Ashtari S, Pourhoseingholi MA, Asadzadeh Aghdaei H, Zali MR. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability. J Gastrointest Cancer 2020;51:53-62. [PMID: 30635874 DOI: 10.1007/s12029-019-00201-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
43 Chunhua L, Donglan L, Xiuqiong F, Lihua Z, Qin F, Yawei L, Liang Z, Ge W, Linlin J, Ping Z, Kun L, Xuegang S. Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT. J Nutr Biochem. 2013;24:1766-1775. [PMID: 23773626 DOI: 10.1016/j.jnutbio.2013.03.006] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 7.4] [Reference Citation Analysis]
44 Manoochehri M, Karbasi A, Bandehpour M, Kazemi B. Down-Regulation of BAX Gene During Carcinogenesis and Acquisition of Resistance to 5-FU in Colorectal Cancer. Pathol Oncol Res 2014;20:301-7. [DOI: 10.1007/s12253-013-9695-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
45 Wan D, He S, Xie B, Xu G, Gu W, Shen C, Hu Y, Wang X, Zhi Q, Wang L. Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers. Med Oncol 2013;30:378. [PMID: 23292866 DOI: 10.1007/s12032-012-0378-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
46 Tsai H, Yang I, Huang C, Ma C, Kuo C, Lu C, Juo S, Wang J. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection. Translational Research 2013;162:258-68. [DOI: 10.1016/j.trsl.2013.07.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
47 Magaji BA, Moy FM, Roslani AC, Law CW. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital. BMC Cancer 2017;17:339. [PMID: 28521746 DOI: 10.1186/s12885-017-3336-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
48 Chaiyasut C, Pattananandecha T, Sirilun S, Suwannalert P, Peerajan S, Sivamaruthi BS. Synbiotic preparation with Lactic acid bacteria and inulin as a functional food: In vivo evaluation of microbial activities, and preneoplastic aberrant crypt foci. Food Sci Technol 2017;37:328-36. [DOI: 10.1590/1678-457x.26216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
49 Yang MH, Rampal S, Sung J, Choi YH, Son HJ, Lee JH, Kim YH, Chang DK, Rhee PL, Kim JJ, Rhee JC, Chun HK, Guallar E, Cho J. The association of serum lipids with colorectal adenomas. Am J Gastroenterol. 2013;108:833-841. [PMID: 23545715 DOI: 10.1038/ajg.2013.64] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
50 Uchiyama K, Naito Y, Yagi N, Mizushima K, Higashimura Y, Hirai Y, Dohi O, Okayama T, Yoshida N, Katada K, Kamada K, Handa O, Ishikawa T, Takagi T, Konishi H, Nonaka D, Asada K, Lee LJ, Tanaka K, Kuriu Y, Nakanishi M, Otsuji E, Itoh Y. Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP®-MS analysis. J Gastroenterol 2018;53:1179-85. [PMID: 29497816 DOI: 10.1007/s00535-018-1448-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
51 Li J, Guo W, Bai Y, Deng Y, Yang L, Chen Z, Zhong H, Xu R, Pan H, Shu Y, Yuan Y, Zhou J, Xu N, Liu T, Ma D, Wu C, Cheng Y, Xu J, Chen D, Li W, Sun S, Yu Z, Cao P, Shen L, Chen H, Wang S, Wang H, Fan S, Guo X, Wang N, Han R, Zhang B, Qin S. Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial. Adv Ther 2020;37:4585-98. [PMID: 32901330 DOI: 10.1007/s12325-020-01477-w] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Chen Z, Liu H, Jin W, Ding Z, Zheng S, Yu Y. Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer - a meta-analysis. Onco Targets Ther. 2016;9:2615-2624. [PMID: 27226723 DOI: 10.2147/ott.s103893] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
53 Akter S, Islam Z, Mizoue T, Sawada N, Ihira H, Tsugane S, Koyanagi YN, Ito H, Wang C, Tamakoshi A, Wada K, Nagata C, Tanaka K, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Shimazu T, Matsuo K, Naito M, Tanaka K, Inoue M. Smoking and colorectal cancer: A pooled analysis of 10 population-based cohort studies in Japan. Int J Cancer 2021;148:654-64. [PMID: 32761607 DOI: 10.1002/ijc.33248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Ruan GT, Gong YZ, Zhu LC, Gao F, Liao XW, Wang XK, Zhu GZ, Liao C, Wang S, Yan L, Xie HL, Zhou X, Liu JQ, Shao MN, Gan JL. The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma. Onco Targets Ther 2020;13:9389-405. [PMID: 33061426 DOI: 10.2147/OTT.S251965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Jamali L, Sadeghi H, Ghasemi MR, Mohseni R, Nazemalhosseini-Mojarad E, Yassaee VR, Larki P, Zali MR, Mirfakhraie R. Autophagy ATG16L1 rs2241880 impacts the colorectal cancer risk: A case-control study. J Clin Lab Anal 2021;:e24169. [PMID: 34894411 DOI: 10.1002/jcla.24169] [Reference Citation Analysis]
56 Akter S, Kashino I, Mizoue T, Matsuo K, Ito H, Wakai K, Nagata C, Nakayama T, Sadakane A, Tanaka K, Tamakoshi A, Sugawara Y, Sawada N, Inoue M, Tsugane S, Sasazuki S. Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Jpn J Clin Oncol 2016;46:781-7. [DOI: 10.1093/jjco/hyw059] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
57 Huang B, Gao YT, Shu XO, Wen W, Yang G, Li G, Courtney R, Ji BT, Li HL, Purdue MP, Zheng W, Cai Q. Association of leukocyte mitochondrial DNA copy number with colorectal cancer risk: Results from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev 2014;23:2357-65. [PMID: 25139937 DOI: 10.1158/1055-9965.EPI-14-0297] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
58 Chen CH, Tsai MK, Wen CP. Extending Colorectal Cancer Screening to Persons Aged 40 to 49 Years With Immunochemical Fecal Occult Blood Test: A Prospective Cohort Study of 513,283 Individuals. J Clin Gastroenterol. 2016;50:761-768. [PMID: 26905605 DOI: 10.1097/mcg.0000000000000495] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
59 Chan KWK, Chung HY, Ho WS. Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro. Molecules 2020;25:E212. [PMID: 31947901 DOI: 10.3390/molecules25010212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Phang CW, Karsani SA, Abd Malek SN. Induction of Apoptosis and Cell Cycle Arrest by Flavokawain C on HT-29 Human Colon Adenocarcinoma via Enhancement of Reactive Oxygen Species Generation, Upregulation of p21, p27, and GADD153, and Inactivation of Inhibitor of Apoptosis Proteins. Pharmacogn Mag 2017;13:S321-8. [PMID: 28808400 DOI: 10.4103/0973-1296.210180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
61 Kou C, Zhou T, Han X, Zhuang H, Qian H. LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer. Biochem Biophys Res Commun 2015;464:519-25. [PMID: 26159916 DOI: 10.1016/j.bbrc.2015.06.173] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
62 Ganepola GA, Nizin J, Rutledge JR, Chang DH. Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J Gastrointest Oncol 2014; 6(4): 83-97 [PMID: 24734154 DOI: 10.4251/wjgo.v6.i4.83] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
63 Levi M, Prayogi G, Sastranagara F, Sudianto E, Widjajahakim G, Gani W, Mahanadi A, Agnes J, Khairunisa BH, Utomo AR. Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort. J Gastrointest Cancer 2018;49:124-31. [PMID: 28044264 DOI: 10.1007/s12029-016-9901-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
64 Peng Q, Zhang X, Min M, Zou L, Shen P, Zhu Y. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8:44893-44909. [PMID: 28415652 DOI: 10.18632/oncotarget.16488] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
65 Liu M, Zhi Q, Wang W, Zhang Q, Fang T, Ma Q. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. Biomed Pharmacother 2015;69:214-20. [PMID: 25661360 DOI: 10.1016/j.biopha.2014.12.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
66 Shin EJ, Sung MJ, Park JH, Yang HJ, Kim MS, Hur HJ, Hwang JT. Poly-γ-glutamic acid induces apoptosis via reduction of COX-2 expression in TPA-induced HT-29 human colorectal cancer cells. Int J Mol Sci 2015;16:7577-86. [PMID: 25854428 DOI: 10.3390/ijms16047577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
67 Choi SH, Kang HY, Choi SY, Kim MN, Yang JI, Chung SJ, Yang SY, Kim YS, Kim JS. Colorectal adenoma is associated with coronary artery calcification in a Korean population. Atherosclerosis 2015;242:515-20. [PMID: 26298744 DOI: 10.1016/j.atherosclerosis.2015.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Muro K, Salinardi T, Singh AR, Macarulla T. Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data. Cancers (Basel) 2020;12:E844. [PMID: 32244546 DOI: 10.3390/cancers12040844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Wang Y, Cui X, Ma S, Zhang H. Decreased expression of miR-3135b reduces sensitivity to 5-fluorouracil in colorectal cancer by direct repression of PIM1. Exp Ther Med 2021;22:1151. [PMID: 34504596 DOI: 10.3892/etm.2021.10585] [Reference Citation Analysis]
70 Vermani L, Kumar R, Senthil Kumar N. GAPDH and PUM1: Optimal Housekeeping Genes for Quantitative Polymerase Chain Reaction-Based Analysis of Cancer Stem Cells and Epithelial-Mesenchymal Transition Gene Expression in Rectal Tumors. Cureus 2020;12:e12020. [PMID: 33457124 DOI: 10.7759/cureus.12020] [Reference Citation Analysis]